LMAT (LeMaitre) Market Value to Book Value Ratio

LeMaitre (LMAT) - corporate logo

LeMaitre Vascular, Inc. (LMAT) is capturing niche segments of vascular surgery, expanding its reach through the acquisition of small brands and the growth of its sales representative workforce. High product profitability and physician loyalty ensure business stability, as confirmed by the market price visualization on GURU.Markets, where the indicator stands at 4.57. The brand's ecosystem integrates the production of unique implants with direct sales, creating an indispensable set of tools for operating rooms.

LMAT - LeMaitre Corp Market-to-Book Ratio over the range 07/04/2022 - 10/28/2026
Manufactured products of LeMaitre Vascular Inc

This indicator reflects the ratio of the company's market value to its net asset value, allowing investors to assess the extent to which the business is overvalued or undervalued relative to the balance sheet. By analyzing the price-to-book value trend, one can see how the high margins of niche implants and surgeon loyalty to LeMaitre Vascular, Inc. (LMAT) instrumentation create a market premium over the cost of capital.

Direct competitors

ISRG - Market Cap to Net Assets Ratio|DHR (danaher.com) - Market Cap to Book Value Multiple|Market Value to Book Value Ratio BDX|Market Cap to Net Assets Ratio STERIS PLC|West Pharmaceutical Services Inc - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Baxter Healthcare (BAX)|MASI - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio stevanatogroup.com STVN|Market Capitalization to Book Value Ratio TFX (Teleflex)|MMSI - Market Capitalization to Book Value|NVST (Envista Holdings Corp) - Market Capitalization to Book Value Ratio|ICU Medical Inc. (ICUI) - Market Cap to Net Assets Ratio|XRAY (DENTSPLY SIRONA Inc.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ATRC|Market Value to Book Value Ratio STAAR Surgical (STAA)|Market Value to Book Value Ratio Chromadex Corp NAGE|Market Cap to Net Assets Ratio ZimVie Dental|Market Value to Book Value AngioDynamics Inc. ANGO|Market Capitalization to Book Value Ratio CERS (Cerus Corporation)|TKNO: Market Capitalization to Book Value|Market Value to Book Value Ratio Monogram Orthopedics|STSS (Sharps Technology) - Capitalization to Book Value Ratio|INFU: Market Value to Book Value Ratio|Market Capitalization to Book Value Utah Med (UTMD)|Market Cap to Net Assets Ratio KORU Medical Systems|Market Cap to Book Value Multiple NYXH (nyxoah.com)|Market Value to Book Value Ratio Microbot Medical|PDEX - Market Value to Book Value|Zentek Limited - Market Cap to Net Assets Ratio|ELUT: Market Capitalization to Book Value Ratio|MLSS (Milestone Scientific) - Market Value to Book Value Ratio|nexgel.com (NXGL) - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio RVP (Retractable Technologies Inc.)|Market-to-Book Ratio HBIO|Market Value to Book Value Ratio Femasys Corp FEMY|Capitalization to Book Value Ratio meihuamed.com MHUA|Market Cap to Net Assets Ratio Predictive Oncology Inc. (POAI)|Callan JMB Inc. - Market Cap to Book Value Multiple|Market Value to Book Value Ratio ATRI (Atrion)|NURO: Market Capitalization to Book Value